About the PMPRB

The PMPRB protects and informs Canadians by ensuring that the prices of patented medicines sold in Canada are not excessive and by reporting on pharmaceutical trends.

CompassRx 4

Biologics in Canada

The Biologics in Canada series examines Canadian and international trends in the sales, cost, use, and pricing of biologics as of the end of 2018.

Find out more…

Market Intelligence Report: Combination Inhalers for Asthma, 2018

This edition of the report analyzes the market for inhaled corticosteroid (ICS) and long-acting beta agonist (LABA) combination inhalers used in the treatment of asthma.

Find out more…

Meds Pipeline Monitor 2019

Horizon scanning report that features a selection of new medicines in the late stages of clinical evaluation that may have a significant impact on future clinical practice and drug spending in Canada.

Find out more…

Meds Entry Watch 2018

Meds Entry Watch 2018

This is the fourth edition of the PMPRB’s Meds Entry Watch report, which explores the market entry of new medicines in Canada and other countries.

Find out more…

SteeringCommittee

The PMPRB is consulting with its stakeholders on changes to its non-binding guidelines (the “Guidelines”), as contemplated by subsection 96(4) of the Patent Act.

Find out more

I am a/an...

Consumer

Patentee

Other Stakeholder

Features

Annual Report 2017

Annual Report

PMPRB NEWSletter

Analytical Studies

The PMPRB has updated its website and the link you have bookmarked is no longer available. In a few seconds you will be redirected to our home page to allow you to locate the content you're looking for.

To go directly to the "Are You a Patentee" page, click here.

If you are not taken to the home page within 10 seconds, click here.

 

 

 

 

 

 

 

 

 

 

 

 

 

Date modified: